H A Lawson1, M Zayed2, J P Wayhart1, E Fabbrini3, L Love-Gregory3, S Klein3, C F Semenkovich3. 1. Department of Genetics, Washington University School of Medicine, St Louis, MO, USA. 2. Department of Surgery, Section of Vascular Surgery, Washington University School of Medicine, St Louis, MO, USA. 3. Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
Abstract
BACKGROUND/ OBJECTIVES: Elevated triglycerides predict insulin resistance and vascular disease in obesity, but how the inert triglyceride molecule is related to development of metabolic disease is unknown. To pursue novel potential mediators of triglyceride-associated metabolic disease, we used a forward genetics approach involving inbred mice and translated our findings to human subjects. SUBJECTS/ METHODS: Hemopexin (HPX) was identified as a differentially expressed gene within a quantitative trait locus associated with serum triglycerides in an F16 advanced intercross between the LG/J and SM/J strains of mice. Hpx expression was evaluated in both the reproductive fat pads and livers of mice representing three strains, LG/J (n=25), SM/J (n=27) and C57Bl/6J (n=19), on high- and low-fat diets. The effect of altered Hpx expression on adipogenesis was studied in 3T3-L1 cells. Circulating HPX protein along with HPX expression were characterized in subcutaneous white adipose tissue samples obtained from a cohort of metabolically abnormal (n=18) and of metabolically normal (n=24) obese human subjects. We further examined the relationship between HPX and triglycerides in human atherosclerotic plaques (n=18). RESULTS: HPX expression in mouse adipose tissue, but not in liver, was regulated by dietary fat regardless of genetic background. HPX increased in concert with adipogenesis in 3T3-L1 cells, and disruption of its expression impaired adipocyte differentiation. RNAseq data from the adipose tissue of obese humans showed differential expression of HPX based on metabolic disease status (P<0.05), and circulating HPX levels were correlated with serum triglycerides in these subjects (r=0.33; P=0.03). HPX was also found in an unbiased proteomic screen of human atherosclerotic plaques and shown to display differential abundance based on the extent of disease and triglyceride content (P<0.05). CONCLUSIONS: Our findings suggest that HPX is associated with triglycerides and provide a framework for understanding mechanisms underlying lipid metabolism and metabolic disease.
BACKGROUND/ OBJECTIVES: Elevated triglycerides predict insulin resistance and vascular disease in obesity, but how the inert triglyceride molecule is related to development of metabolic disease is unknown. To pursue novel potential mediators of triglyceride-associated metabolic disease, we used a forward genetics approach involving inbred mice and translated our findings to human subjects. SUBJECTS/ METHODS:Hemopexin (HPX) was identified as a differentially expressed gene within a quantitative trait locus associated with serum triglycerides in an F16 advanced intercross between the LG/J and SM/J strains of mice. Hpx expression was evaluated in both the reproductive fat pads and livers of mice representing three strains, LG/J (n=25), SM/J (n=27) and C57Bl/6J (n=19), on high- and low-fat diets. The effect of altered Hpx expression on adipogenesis was studied in 3T3-L1 cells. Circulating HPX protein along with HPX expression were characterized in subcutaneous white adipose tissue samples obtained from a cohort of metabolically abnormal (n=18) and of metabolically normal (n=24) obesehuman subjects. We further examined the relationship between HPX and triglycerides in humanatherosclerotic plaques (n=18). RESULTS:HPX expression in mouse adipose tissue, but not in liver, was regulated by dietary fat regardless of genetic background. HPX increased in concert with adipogenesis in 3T3-L1 cells, and disruption of its expression impaired adipocyte differentiation. RNAseq data from the adipose tissue of obesehumans showed differential expression of HPX based on metabolic disease status (P<0.05), and circulating HPX levels were correlated with serum triglycerides in these subjects (r=0.33; P=0.03). HPX was also found in an unbiased proteomic screen of humanatherosclerotic plaques and shown to display differential abundance based on the extent of disease and triglyceride content (P<0.05). CONCLUSIONS: Our findings suggest that HPX is associated with triglycerides and provide a framework for understanding mechanisms underlying lipid metabolism and metabolic disease.
Authors: J P Swerts; C Soula; Y Sagot; M J Guinaudy; J C Guillemot; P Ferrara; A M Duprat; P Cochard Journal: J Biol Chem Date: 1992-05-25 Impact factor: 5.157
Authors: J Scott Gabrielsen; Yan Gao; Judith A Simcox; Jingyu Huang; David Thorup; Deborah Jones; Robert C Cooksey; David Gabrielsen; Ted D Adams; Steven C Hunt; Paul N Hopkins; William T Cefalu; Donald A McClain Journal: J Clin Invest Date: 2012-09-10 Impact factor: 14.808
Authors: Elisa Fabbrini; Jun Yoshino; Mihoko Yoshino; Faidon Magkos; Courtney Tiemann Luecking; Dmitri Samovski; Gemma Fraterrigo; Adewole L Okunade; Bruce W Patterson; Samuel Klein Journal: J Clin Invest Date: 2015-01-02 Impact factor: 14.808
Authors: Charlyn G Partridge; Gloria L Fawcett; Bing Wang; Clay F Semenkovich; James M Cheverud Journal: BMC Genomics Date: 2014-02-05 Impact factor: 3.969
Authors: Mario A Miranda; Celine L St Pierre; Juan F Macias-Velasco; Huyen Anh Nguyen; Heather Schmidt; Lucian T Agnello; Jessica P Wayhart; Heather A Lawson Journal: Nutr Metab (Lond) Date: 2019-02-18 Impact factor: 4.169
Authors: Álvaro González-Domínguez; Francisco M Visiedo-García; Jesús Domínguez-Riscart; Raúl González-Domínguez; Rosa M Mateos; Alfonso María Lechuga-Sancho Journal: Int J Mol Sci Date: 2020-08-01 Impact factor: 5.923